BERGEN, Norway, Dec. 15, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Marine Harvest ASA (the "Company") has resolved to offer all permanent employees in the Company and its Norwegian, Scottish and Canadian subsidiaries the opportunity to purchase shares in the Company at a discounted price.
The offer to the employees is based on the volume weighted price for the Company's shares on 14 December 2015 of NOK 110.9767 per share.
The Norwegian Tax Act §5-14 provides Norwegian employees with a right to purchase shares with a discount of up to NOK 1,500 in such offer. Based on the above, eligible employees in Norway have been given two alternative offers. Alternative 1 is the purchase of 68 shares at a value of approximately NOK 7,500 with a tax-free discount of NOK 1,500 at a purchase price around NOK 6,000. Alternative 2 is the purchase of 136 shares at a value of approximately NOK 15,000 with a tax-free discount of NOK 1,500 and a taxable discount of NOK 1,500, at a purchase price around NOK 12,000.
Eligible employees in Scotland and Canada were given the same offers, however without any element of tax-free discount.
At the end of the acceptance period, the Company had received acceptances of these offers from 421 employees for a total of 52,904 shares. In order to comply with its obligation in relation to the acceptances received, the Company has, on 14 December 2015, purchased 11,934 shares in the market at an average price of NOK 112.1250. The outstanding number of shares required to fulfil the above obligation will be satisfied by selling 40,970 own shares held in Treasury. In total 52,904 shares will be sold to the employees having accepted to participate in the share program on the terms referred to above.
Subsequent to these transactions, the Company holds zero own shares.
The following primary insiders in the company have been allocated shares according to the above and have, following this and adjustments for dividends paid, the following number of shares and options in the company:
| Shares acquired | Total number of | Total options | |
| Name | on 14 December | shares owned | allotted |
|
Alf-Helge Aarskog (CEO) |
136 | 138 570 | 2 268 030 |
|
Ivan Vindheim (CFO) |
136 | 660 | 453 606 |
|
Marit Solberg (COO Farming) |
136 | 47 813 | 453 606 |
|
Ola Brattvoll (COO Sales & Marketing) |
136 | 9 231 | 453 606 |
|
Ben Hadfield (COO Fish Feed) |
136 | 6 870 | 258 993 |
|
Øyvind Oaland (Global Director R&D) |
136 | 19 388 | 48 653 |
|
Anne Lorgen Riise (Global Director HR) |
136 | 358 | 48 653 |
|
Kristine Gramstad (Communications Director) |
136 | 136 | 0 |
|
Kim Galtung Døsvig (Investor Relations & Head of Treasury) |
136 | 136 | 0 |
|
Lars Eirik Hestnes (Board member, employee representative) |
136 | 136 | 0 |
This information is subject to the disclosure requirements pursuant to section 4-2 and 5-12 of the Norwegian Securities Trading Act.
HUG#1973468
CONTACT: For further information, please contact:
Marine Harvest media: +47 48 18 99 00


Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 



